Hugo Tovar is an expert in Biochemistry at National Institute of Genomic Medicine (Mexico). Hugo Tovar has authored 27 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 67 (community average: 125). How the SLR is computed.

LeadR Profile

67 ScienceLeadR Reputation 67
Network Map

Biochemistry

Subspecialties: Endocrinology - Pulmonology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2015 - 2026

Source: PubMed

National Institute of Genomic Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 27

Citations

Citations: 548 1st author: 2 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A β-Hydroxybutyrylation-FOXM1/CENPA Axis Links Ketone-Body Metabolism to Mitotic Transcription in Basal-like Breast Cancer.
PMID 42589710 — breast neoplasms, neoplasms, ketones, histones, breast
Int J Mol Sci20260
Genome-wide identification and characterization of the carotenoid cleavage dioxygenase gene family in Bixa orellana L.
PMID 42483508 — genes, dioxygenases, promoter regions, genetic, stress, physiological, genome, seeds, hormones, exons, carotenoids, synteny
Front Plant Sci20260
Prediction of myeloid malignant cells in Fanconi anemia using machine learning.
PMID 41557613 — cells, anemia, aplastic, bone marrow, anemia, neoplasms, machine learning, fanconi anemia, work, learning
PLoS One20260
Two Cohorts, One Network: Consensus Master Regulators Orchestrating Papillary Thyroid Carcinoma.
PMID 41303715 — thyroid cancer, papillary, genes, gene regulatory networks, neoplasms, thyroid gland
Int J Mol Sci20250
Prenatal exposure to Bisphenol-A as a risk factor for infant neurodevelopment.
PMID 40951437 — neurodevelopmental disorders, risk factors, child, infant, neurodevelopment
Front Endocrinol (Lausanne)20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map